Although KRAS mutations have been linked to hepatic angiosarcoma in other studies, we did not find a significant difference in KRAS mutation frequency between hepatic and breast angiosarcomas (p = 1.00) [7]. This evidence concerns the gene KRAS and liver angiosarcoma.